新生児黄疸治療市場レポート：2031年までの動向、予測、競合分析

世界の新生児黄疸治療市場は、病院市場と家庭市場に機会があり、将来性が期待されます。世界の新生児黄疸治療市場は、2025年から2031年にかけてCAGR 4.1％で成長すると予測されます。この市場の主な促進要因は、世界の新生児黄疸の罹患率の上昇、親やヘルスケアプロバイダーの意識の高まり、高度な光線療法機器の利用可能性の増加です。

• Lucintelでは、タイプ別ではポータブル光線治療器が予測期間中に高い成長を遂げると予測しています。
• 用途別では、病院が高い成長が見込まれています。
• 地域別では、アジア太平洋が予測期間で最も高い成長が見込まれます。

150ページ以上の包括的なレポートで、ビジネス上の意思決定に役立つ貴重な洞察を得ることができます。いくつかの洞察を含むサンプル図を以下に示します。

新生児黄疸治療市場の新たな動向

新生児黄疸治療市場は、技術の進歩、患者中心のケア、手頃な価格のソリューションに対する世界の需要に後押しされ、その将来を決定づける様々な新たな動向に見舞われています。

• LED光線療法技術の進歩：LEDを使用した光線療法機器の普及は重要な動向です。LEDは従来の蛍光灯に比べて、長寿命、エネルギー使用量の削減、治療用波長の光を放射する能力など、いくつかの利点があり、その結果、より効果的で潜在的に安全なビリルビンの減少が期待できます。この技術は病院では標準となりつつあり、携帯型機器にも組み込まれつつあります。
• 携帯型および家庭用光線療法装置の開発：医師の指導の下、家庭で使用できる小型で使いやすい光線療法装置の開発に関心が高まっています。このような装置は、ビリルビン値の低い新生児に効果的な治療を提供する一方で、入院期間の短縮、家族への迷惑の軽減、ヘルスケアコストの削減をもたらすと期待されています。そのためには、強力な安全機能と家庭での使用に関する簡単な説明書が必要です。
• 非侵襲的ビリルビンモニタリングの統合：経皮的ビリルビン濃度計のような非侵襲的ビリルビン測定装置の開発と使用の拡大は、大きな動向です。これらは、採血を繰り返すことなく、迅速かつ苦痛なくビリルビン濃度をスクリーニングするために使用され、新生児のストレスを最小限に抑え、必要な時にタイムリーな介入を可能にします。この技術は、黄疸の早期診断と進行のモニタリングに役立ちます。
• 個別化・最適化された光線療法の重視：現在の調査では、妊娠月齢、体重、黄疸の原因など、個々の新生児の特徴に応じて光線療法をカスタマイズすることも重視されています。また、脱水や皮膚刺激などの副作用を最小限に抑えながらビリルビンを最大に減少させるために、放射照度レベルや光線療法時間を最適化することも重要です。
• 遠隔医療と遠隔モニタリングソリューション：新生児黄疸ケアにおける遠隔医療と遠隔モニタリング技術の利用は新しい動向です。これにより、特に在宅光線療法を受けている新生児を対象に、医療提供者によるビリルビン値や治療経過の遠隔モニタリングが可能になります。これにより、専門医による治療へのアクセスが向上し、タイムリーな治療計画の調整が可能になります。

このような新しい動向は、新生児黄疸治療市場を、より効率的で安全な、患者本位のソリューションへと変化させつつあります。LED技術の開発、ポータブル機器の開発、非侵襲的モニタリング、カスタマイズされた治療プロトコル、遠隔医療の導入はすべて、新生児とその家族にとってより良い治療経験と治療成績の向上に向かっています。

新生児黄疸治療市場の最近の動向

新生児黄疸治療市場は最近の動向として、有効性、安全性、治療へのアクセスの改善に焦点を当てたいくつかの主な発展を遂げています。

• 光線療法装置のスペクトル出力の最適化：光線療法装置の最近の動向には、皮膚損傷やその他の副作用のリスクを最小限に抑えながらビリルビンの最大吸収を達成するために、照射される光のスペクトルを最適化することが含まれています。これには、ビリルビンを水溶性異性体に変換して排泄するのに最も効果的な青緑色光の特定の波長を適用することが含まれます。
• 高輝度狭帯域LEDシステム開発：高強度ナローバンドLED光線療法システムの利用により、より短時間でより特異的なビリルビン減少が可能となります。これらのシステムは治療光を集中的に照射するため、重度の黄疸を有する新生児の光線療法の経過や入院期間を短縮できる可能性があります。
• 光線療法機器へのインテリジェント機能の搭載：最新の光線治療器には、自動照射制御、治療時間のモニタリング、記録のロギングなどのインテリジェントな機能が搭載されています。このような機能により、治療者は十分に制御された最大限の治療を提供し、体系的に経過を追跡し、適切な記録を確実に残すことができます。
• 光ファイバー光治療ブランケットの開発：新生児の皮膚に直接光を照射する光ファイバー光線療法ブランケットは、強度と照射範囲が改善されています。毛布は、新生児の扱いや授乳がより簡単になると同時に、24時間体制での治療に特に便利です。
• 両親と介護者のための教育リソース：黄疸のある新生児の家庭でのケアにおいて両親や介護者が果たす重要な役割を認識し、新生児の黄疸、その管理、家庭用光線治療器の安全な家庭での使用に関する広範な教育資料の作成に重点を置いています。

新生児黄疸治療市場におけるこのような最近の進歩は、より良く、より安全で、より使いやすい治療を提供することで、新生児ケアに大きな影響を与えています。光出力の最大化、インテリジェントな機能、コンパクトな機器、教育の強化が重視され、新生児とその家族にとってより良い治療結果と経験の向上につながっています。

目次

第1章 エグゼクティブサマリー

第2章 世界の新生児黄疸治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• PESTLE分析
• 特許分析
• 規制環境
• 業界の促進要因と課題

第3章 市場動向と予測分析 （2019年～2031年）

• マクロ経済動向（2019年～2024年）と予測（2025年～2031年）
• 新生児黄疸治療の世界市場動向（2019年～2024年）と予測（2025年～2031年）
• 世界の新生児黄疸治療市場：タイプ別
  • オーバーヘッド光線療法ユニット：動向と予測（2019年～2031年）
  • ポータブル光線療法装置：動向と予測（2019年～2031年）
  • その他：動向と予測（2019年～2031年）
• 世界の新生児黄疸治療市場：用途別
  • 病院：動向と予測（2019年～2031年）
  • 世帯：動向と予測（2019年～2031年）
  • その他：動向と予測（2019年～2031年）

第4章 市場動向と予測分析：地域別（2019年～2031年）

• 新生児黄疸治療市場：地域別
• 北米の新生児黄疸治療市場
• 欧州の新生児黄疸治療市場
• アジア太平洋地域の新生児黄疸治療市場
• その他地域の新生児黄疸治療市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威

第6章 成長機会と戦略分析

• 成長機会分析
  • 新生児黄疸治療市場における成長機会：タイプ別
  • 新生児黄疸治療市場における成長機会：用途別
  • 新生児黄疸治療市場における成長機会：地域別
• 世界の新生児黄疸治療市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界の新生児黄疸治療市場の能力拡大
  • 世界の新生児黄疸治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• GE Healthcare
• Drager
• Bilimetrix
• Philips
• Atom Medical
• Nice Neotech
• MTTS
• Natus Medical
• Delta
• Micro Lab

List of Figures

• Figure 2.1: Classification of the Global Newborn Jaundice Treatment Market
• Figure 2.2: Supply Chain of the Global Newborn Jaundice Treatment Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 3.19: Global Newborn Jaundice Treatment Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 3.20: Trends of the Global Newborn Jaundice Treatment Market ($B) by Type (2019-2024)
• Figure 3.21: Forecast for the Global Newborn Jaundice Treatment Market ($B) by Type (2025-2031)
• Figure 3.22: Trends and Forecast for Overhead Phototherapy Units in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 3.23: Trends and Forecast for Portable Phototherapy Units in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 3.24: Trends and Forecast for Others in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 3.25: Global Newborn Jaundice Treatment Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 3.26: Trends of the Global Newborn Jaundice Treatment Market ($B) by Application (2019-2024)
• Figure 3.27: Forecast for the Global Newborn Jaundice Treatment Market ($B) by Application (2025-2031)
• Figure 3.28: Trends and Forecast for Hospital in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 3.29: Trends and Forecast for Household in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 3.30: Trends and Forecast for Others in the Global Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.1: Trends of the Global Newborn Jaundice Treatment Market ($B) by Region (2019-2024)
• Figure 4.2: Forecast for the Global Newborn Jaundice Treatment Market ($B) by Region (2025-2031)
• Figure 4.3: Trends and Forecast for the North American Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.4: North American Newborn Jaundice Treatment Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.5: Trends of the North American Newborn Jaundice Treatment Market ($B) by Type (2019-2024)
• Figure 4.6: Forecast for the North American Newborn Jaundice Treatment Market ($B) by Type (2025-2031)
• Figure 4.7: North American Newborn Jaundice Treatment Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.8: Trends of the North American Newborn Jaundice Treatment Market ($B) by Application (2019-2024)
• Figure 4.9: Forecast for the North American Newborn Jaundice Treatment Market ($B) by Application (2025-2031)
• Figure 4.10: Trends and Forecast for the United States Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.11: Trends and Forecast for the Mexican Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.12: Trends and Forecast for the Canadian Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.13: Trends and Forecast for the European Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.14: European Newborn Jaundice Treatment Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.15: Trends of the European Newborn Jaundice Treatment Market ($B) by Type (2019-2024)
• Figure 4.16: Forecast for the European Newborn Jaundice Treatment Market ($B) by Type (2025-2031)
• Figure 4.17: European Newborn Jaundice Treatment Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.18: Trends of the European Newborn Jaundice Treatment Market ($B) by Application (2019-2024)
• Figure 4.19: Forecast for the European Newborn Jaundice Treatment Market ($B) by Application (2025-2031)
• Figure 4.20: Trends and Forecast for the German Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.21: Trends and Forecast for the French Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.22: Trends and Forecast for the Spanish Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.23: Trends and Forecast for the Italian Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.24: Trends and Forecast for the United Kingdom Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.25: Trends and Forecast for the APAC Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.26: APAC Newborn Jaundice Treatment Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.27: Trends of the APAC Newborn Jaundice Treatment Market ($B) by Type (2019-2024)
• Figure 4.28: Forecast for the APAC Newborn Jaundice Treatment Market ($B) by Type (2025-2031)
• Figure 4.29: APAC Newborn Jaundice Treatment Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.30: Trends of the APAC Newborn Jaundice Treatment Market ($B) by Application (2019-2024)
• Figure 4.31: Forecast for the APAC Newborn Jaundice Treatment Market ($B) by Application (2025-2031)
• Figure 4.32: Trends and Forecast for the Japanese Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.33: Trends and Forecast for the Indian Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.34: Trends and Forecast for the Chinese Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.35: Trends and Forecast for the South Korean Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.36: Trends and Forecast for the Indonesian Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.37: Trends and Forecast for the ROW Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.38: ROW Newborn Jaundice Treatment Market by Type in 2019, 2024, and 2031 ($Billion)
• Figure 4.39: Trends of the ROW Newborn Jaundice Treatment Market ($B) by Type (2019-2024)
• Figure 4.40: Forecast for the ROW Newborn Jaundice Treatment Market ($B) by Type (2025-2031)
• Figure 4.41: ROW Newborn Jaundice Treatment Market by Application in 2019, 2024, and 2031 ($Billion)
• Figure 4.42: Trends of the ROW Newborn Jaundice Treatment Market ($B) by Application (2019-2024)
• Figure 4.43: Forecast for the ROW Newborn Jaundice Treatment Market ($B) by Application (2025-2031)
• Figure 4.44: Trends and Forecast for the Middle Eastern Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.45: Trends and Forecast for the South American Newborn Jaundice Treatment Market (2019-2031)
• Figure 4.46: Trends and Forecast for the African Newborn Jaundice Treatment Market (2019-2031)
• Figure 5.1: Porter's Five Forces Analysis for the Global Newborn Jaundice Treatment Market
• Figure 6.1: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Type
• Figure 6.2: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Application
• Figure 6.3: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Region
• Figure 6.4: Emerging Trends in the Global Newborn Jaundice Treatment Market

List of Table

• Table 1.1: Growth Rate (%, 2019-2024) and CAGR (%, 2025-2031) of the Newborn Jaundice Treatment Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Newborn Jaundice Treatment Market by Region
• Table 1.3: Global Newborn Jaundice Treatment Market Parameters and Attributes
• Table 3.1: Trends of the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.2: Forecast for the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.3: Attractiveness Analysis for the Global Newborn Jaundice Treatment Market by Type
• Table 3.4: Market Size and CAGR of Various Type in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.5: Market Size and CAGR of Various Type in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.6: Trends of Overhead Phototherapy Units in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.7: Forecast for the Overhead Phototherapy Units in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.8: Trends of Portable Phototherapy Units in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.9: Forecast for the Portable Phototherapy Units in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.10: Trends of Others in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.11: Forecast for the Others in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.12: Attractiveness Analysis for the Global Newborn Jaundice Treatment Market by Application
• Table 3.13: Market Size and CAGR of Various Application in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.14: Market Size and CAGR of Various Application in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.15: Trends of Hospital in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.16: Forecast for the Hospital in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.17: Trends of Household in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.18: Forecast for the Household in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 3.19: Trends of Others in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 3.20: Forecast for the Others in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 4.1: Market Size and CAGR of Various Regions in the Global Newborn Jaundice Treatment Market (2019-2024)
• Table 4.2: Market Size and CAGR of Various Regions in the Global Newborn Jaundice Treatment Market (2025-2031)
• Table 4.3: Trends of the North American Newborn Jaundice Treatment Market (2019-2024)
• Table 4.4: Forecast for the North American Newborn Jaundice Treatment Market (2025-2031)
• Table 4.5: Market Size and CAGR of Various Type in the North American Newborn Jaundice Treatment Market (2019-2024)
• Table 4.6: Market Size and CAGR of Various Type in the North American Newborn Jaundice Treatment Market (2025-2031)
• Table 4.7: Market Size and CAGR of Various Application in the North American Newborn Jaundice Treatment Market (2019-2024)
• Table 4.8: Market Size and CAGR of Various Application in the North American Newborn Jaundice Treatment Market (2025-2031)
• Table 4.9: Trends of the European Newborn Jaundice Treatment Market (2019-2024)
• Table 4.10: Forecast for the European Newborn Jaundice Treatment Market (2025-2031)
• Table 4.11: Market Size and CAGR of Various Type in the European Newborn Jaundice Treatment Market (2019-2024)
• Table 4.12: Market Size and CAGR of Various Type in the European Newborn Jaundice Treatment Market (2025-2031)
• Table 4.13: Market Size and CAGR of Various Application in the European Newborn Jaundice Treatment Market (2019-2024)
• Table 4.14: Market Size and CAGR of Various Application in the European Newborn Jaundice Treatment Market (2025-2031)
• Table 4.15: Trends of the APAC Newborn Jaundice Treatment Market (2019-2024)
• Table 4.16: Forecast for the APAC Newborn Jaundice Treatment Market (2025-2031)
• Table 4.17: Market Size and CAGR of Various Type in the APAC Newborn Jaundice Treatment Market (2019-2024)
• Table 4.18: Market Size and CAGR of Various Type in the APAC Newborn Jaundice Treatment Market (2025-2031)
• Table 4.19: Market Size and CAGR of Various Application in the APAC Newborn Jaundice Treatment Market (2019-2024)
• Table 4.20: Market Size and CAGR of Various Application in the APAC Newborn Jaundice Treatment Market (2025-2031)
• Table 4.21: Trends of the ROW Newborn Jaundice Treatment Market (2019-2024)
• Table 4.22: Forecast for the ROW Newborn Jaundice Treatment Market (2025-2031)
• Table 4.23: Market Size and CAGR of Various Type in the ROW Newborn Jaundice Treatment Market (2019-2024)
• Table 4.24: Market Size and CAGR of Various Type in the ROW Newborn Jaundice Treatment Market (2025-2031)
• Table 4.25: Market Size and CAGR of Various Application in the ROW Newborn Jaundice Treatment Market (2019-2024)
• Table 4.26: Market Size and CAGR of Various Application in the ROW Newborn Jaundice Treatment Market (2025-2031)
• Table 5.1: Market Presence of Major Players in the Global Newborn Jaundice Treatment Market
• Table 5.2: Operational Integration of the Global Newborn Jaundice Treatment Market
• Table 6.1: New Product Launch by a Major Newborn Jaundice Treatment Producer (2019-2024)

The future of the global newborn jaundice treatment market looks promising with opportunities in the hospital and household markets. The global newborn jaundice treatment market is expected to grow with a CAGR of 4.1% from 2025 to 2031. The major drivers for this market are the rising incidence of neonatal jaundice worldwide, the growing awareness among parents & healthcare providers, and the increasing availability of advanced phototherapy devices.

• Lucintel forecasts that, within the type category, portable phototherapy unit is expected to witness higher growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Newborn Jaundice Treatment Market

The market for newborn jaundice treatment is experiencing various emerging trends that are defining its future, fueled by technological advancements, patient-centered care, and the demand for affordable solutions worldwide.

• LED Phototherapy Technology Advances: The growing use of LED-based phototherapy equipment is a key trend. LEDs have several benefits over conventional fluorescent lamps, such as longer life, reduced energy usage, and the capacity to emit light in therapeutic wavelengths, resulting in more effective and potentially safer bilirubin reduction. This technology is becoming the norm in hospitals and is also being integrated into portable devices.
• Portable and Home-Based Phototherapy Device Development: There is increasing interest in the development of small and easy-to-use phototherapy devices for home use under medical guidance. Such devices are expected to shorten hospital stays, cause less disruption to the family, and reduce healthcare costs while providing effective treatment for newborns with lower bilirubin levels. This necessitates strong safety features and simple instructions for home use.
• Integration of Non-Invasive Bilirubin Monitoring: Development and expanding use of non-invasive bilirubin measuring equipment, like transcutaneous bilirubinometers, is a major trend. These are used to quickly and painlessly screen bilirubin levels without repeated blood sampling, minimizing newborn stress and allowing for timely intervention when required. This technology assists in early diagnosis and monitoring of jaundice progression.
• Emphasis on Personalized and Optimized Phototherapy: Current research is also emphasizing the customization of phototherapy treatment according to individual newborn characteristics, including gestational age, weight, and the cause of jaundice. This also involves optimizing irradiance levels and phototherapy duration to maximize bilirubin reduction with the least possible side effects such as dehydration or skin irritation.
• Telemedicine and Remote Monitoring Solutions: The use of telemedicine and remote monitoring technologies in newborn jaundice care is a new trend. This enables remote monitoring of bilirubin levels and treatment progress by healthcare providers, particularly for newborns undergoing home-based phototherapy. This improves access to specialist care and allows for timely treatment plan adjustments.

These new trends are transforming the market for newborn jaundice treatment towards more efficient, safer, and patient-focused solutions. Progress in LED technology, portable device development, non-invasive monitoring, customized treatment protocols, and telemedicine incorporation are all working towards enhanced outcomes and a better experience for newborns and families.

Recent Developments in the Newborn Jaundice Treatment Market

The newborn jaundice treatment market has seen several key developments recently, focusing on improving the efficacy, safety, and accessibility of care.

• Optimized Spectral Output of Phototherapy Devices: Recent developments in phototherapy equipment include the optimization of the spectrum of light emitted to achieve maximum absorption of bilirubin with minimum risk of skin damage and other side effects. This involves the application of particular wavelengths of blue-green light that are most effective in converting bilirubin to water-soluble isomers for excretion.
• High-Intensity Narrow-Band LED System Development: The availability of high-intensity, narrow-band LED phototherapy systems enables more specific bilirubin reduction within a shorter period. These systems provide a focused dose of therapeutic light, which may shorten the course of phototherapy and hospital stays for newborns with severe jaundice.
• Inclusion of Intelligent Features in Phototherapy Equipment: Contemporary phototherapy equipment is embracing intelligent features including automatic irradiance control, monitoring of treatment times, and record logging. The features enable practitioners to provide well-controlled and maximized treatment, track progress systematically, and ensure proper records are kept.
• Developments in Fiber Optic Phototherapy Blankets: Fiber optic phototherapy blankets, which provide light to the newborn's skin directly, have undergone improvements in intensity and coverage. Blankets are especially convenient for around-the-clock treatment while enabling greater ease in handling and feeding the newborn.
• Educational Resources for Parents and Caregivers: In an acknowledgment of the critical role played by parents and caregivers in caring for newborns with jaundice at home, there is a focus on creating extensive educational materials regarding newborn jaundice, its management, and safe home use of home phototherapy machines.

These recent advances in the newborn jaundice treatment market are having a profound effect on neonatal care by offering better, safer, and easier-to-use treatment. The emphasis on maximized light output, intelligent features, compact devices, and increased education is leading to better outcomes and an improved experience for newborns and their families.

Strategic Growth Opportunities in the Newborn Jaundice Treatment Market

The market of newborn jaundice treatment poses a number of strategic growth possibilities by fulfilling unserved needs within different healthcare scenarios and patient segments.

• Inauguration of Home-Based Treatment Services: In view of safer and more efficacious portable devices for phototherapy, there remains a huge prospect for the escalation of home-based treatment services of newborns experiencing mild to moderate jaundice. This is likely to decelerate rehospitalization rates, decrease expenditures on healthcare, and enhance the bonding and satisfaction of parents.
• Low-Resource Setting Jaundice Management Solutions Development: The development of affordable, robust, and user-friendly phototherapy devices tailored to low-resource settings, along with training for health workers, can mitigate the huge burden of newborn jaundice in developing nations and enhance access to critical care.
• Well-Baby Clinic Jaundice Screening: Using non-invasive bilirubinometers in well-baby clinics and primary care facilities to perform routine bilirubin screening can enable early detection of jaundice and prompt intervention, preventing severe hyperbilirubinemia and its related problems.
• Personalized Phototherapy Protocols: Leveraging research and data analytics to create individualized phototherapy treatment protocols depending on specific newborn traits will help maximize treatment outcomes and reduce side effects to result in improved results.
• Design of Extensive Jaundice Management Platforms: The establishment of comprehensive, integrated platforms including non-invasive screening instruments, phototherapy lamps with remote monitoring, and education for parents and healthcare providers has the potential to simplify the care of newborn jaundice and enhance coordination among various settings.

These strategic expansion opportunities in the newborn jaundice treatment market are centered around enhancing accessibility, affordability, and personalization of care. By scaling up home-based services, creating solutions for low-resource environments, integrating screening into routine practice, personalizing treatment protocols, and building comprehensive management platforms, the market can have a very significant influence on the health and well-being of newborns around the world.

Newborn Jaundice Treatment Market Driver and Challenges

The key drivers for the newborn jaundice treatment market are the high prevalence of neonatal jaundice worldwide, growing awareness of its possible complications, and improved phototherapy technology. On the other hand, the market has challenges like the expense of advanced treatment equipment, the necessity for efficient screening programs, and maintaining accessibility of treatment in low-resource environments.

The factors responsible for driving the newborn jaundice treatment market include:

1. High Prevalence of Newborn Jaundice: Newborn jaundice is an extremely prevalent condition globally, occurring in a high percentage of newborn babies. This high prevalence makes a large and steady demand for efficient treatment options necessary to avoid bilirubin neurotoxicity.

2. Increasing Awareness of Potential Complications: Increased awareness of healthcare professionals and parents regarding the possible long-term neurological complications of untreated severe jaundice (kernicterus) is fueling demand for early detection and successful treatment interventions.

3. Advances in Phototherapy Technology: Ongoing innovations in phototherapy equipment, specifically the advancement of more effective and safer LED-based systems, are fueling market growth through improved treatment results and fewer side effects.

4. Focus on Early Detection and Intervention: Healthcare recommendations and guidelines more and more focus on the need for early bilirubin screening and timely phototherapy initiation if necessary, thus increasing the need for bilirubin measurement devices and phototherapy machines.

5. Government and Healthcare Initiatives: Government and healthcare agencies are launching programs and guidelines to enhance newborn care, such as jaundice management, which typically entails investments in treatment and screening infrastructure.

Challenges in the newborn jaundice treatment market are:

1. Advanced Treatment Devices' Cost: High-end phototherapy devices with high-end features and non-invasive bilirubin monitors are costly, thus becoming a deterrent to adoption, especially in settings where resources are limited and small healthcare facilities exist.

2. Demand for Efficient Screening Programs: As important as screening is, organizing and implementing effective and extensive bilirubin screening programs, particularly in developing nations, can prove to be problematic owing to logistic and resource-related limitations.

3. Providing Accessibility in Low-Resource Areas: Facilitating access to the proper jaundice care, especially phototherapy, in remote and underprivileged regions with limited facilities and trained healthcare professionals is a major challenge in the world.

The newborn jaundice treatment market is dominated by the high prevalence of the condition, growing awareness of its hazards, and phototherapy technology advancements. Challenges associated with the expense of sophisticated devices, the implementation of efficient screening programs, and maintaining accessibility in low-resource environments must be met to further enhance outcomes among newborns with jaundice globally.

List of Newborn Jaundice Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies newborn jaundice treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the newborn jaundice treatment companies profiled in this report include-

• GE Healthcare
• Drager
• Bilimetrix
• Philips
• Atom Medical
• Nice Neotech
• MTTS
• Natus Medical
• Delta
• Micro Lab

Newborn Jaundice Treatment Market by Segment

The study includes a forecast for the global newborn jaundice treatment market by type, application, and region.

Newborn Jaundice Treatment Market by Type [Value from 2019 to 2031]:

• Overhead Phototherapy Units
• Portable Phototherapy Units
• Others

Newborn Jaundice Treatment Market by Application [Value from 2019 to 2031]:

• Hospital
• Household
• Others

Newborn Jaundice Treatment Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Newborn Jaundice Treatment Market

Newborn jaundice, a relatively common condition in newborns involving yellowing of the skin and eyes, requires safe and affordable treatment to avoid future neurological issues. New advancements in the treatment of newborn jaundice in the market center on improving the effectiveness and safety of phototherapy, the main treatment. Advancements comprise improvements in light-emitting diode (LED) technology, the introduction of portable and home phototherapy equipment, and enhanced diagnostic equipment for early identification and monitoring of bilirubin levels. This context provides the backdrop for reviewing country-specific advances in this critical area of medicine.

• United States: The United States market focuses on high-technology phototherapy systems with accurate spectral output and control of irradiance to maximize bilirubin decrease with a minimum of possible side effects. New innovations involve embedding these systems into electronic health records for hassle-free data handling and creating user-friendly, hospital-grade phototherapy units for home usage with medical supervision aimed at decreasing hospitalization and healthcare expenditures.
• China: Having a high birth rate, China is a major market for newborn jaundice treatment. New trends include the growing use of LED phototherapy devices instead of conventional fluorescent lamps because they are energy-efficient and have a longer lifespan. Increased emphasis is also being placed on enhancing access to phototherapy in rural regions through the creation of more portable and cheaper treatment methods, combined with better training for healthcare workers in neonatal care.
• Germany: Germany's newborn jaundice treatment market is dominated by emphasis on quality and technologically superior medical devices. Recent advancements involve the introduction of advanced phototherapy units with integrated irradiance sensors and feedback loops to deliver optimal treatment. Research and development activities also focus on the long-term neurodevelopmental outcomes of jaundiced newborns and optimizing treatment protocols based on that.
• India: India faces a substantial burden of newborn jaundice, particularly in rural and underserved communities. Recent advancements include the development of cost-effective and sturdy phototherapy devices appropriate for low-resource settings. Increased focus has also been directed towards community-based jaundice screening initiatives and training of frontline healthcare workers at the primary care level to enable early diagnosis and prompt implementation of phototherapy, enhancing access to basic treatment.
• Japan: The Japanese market places a priority on gentle yet effective newborn care. Recent innovation in jaundice treatment includes improvement of phototherapy protocols to keep treatment times to a minimum and reduce the possibility of newborn stress. In addition, interest in non-invasive bilirubin monitoring instruments for decreased necessity for repeated blood testing, together with the employment of high-grade LED phototherapy equipment with light output optimized for effective and safe reduction of bilirubin, has been demonstrated.

Features of the Global Newborn Jaundice Treatment Market

• Market Size Estimates: Newborn jaundice treatment market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Newborn jaundice treatment market size by type, application, and region in terms of value ($B).
• Regional Analysis: Newborn jaundice treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the newborn jaundice treatment market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the newborn jaundice treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the newborn jaundice treatment market by type (overhead phototherapy units, portable phototherapy units, and others), application (hospital, household, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Newborn Jaundice Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: PESTLE Analysis
• 2.4: Patent Analysis
• 2.5: Regulatory Environment
• 2.6: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Newborn Jaundice Treatment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Newborn Jaundice Treatment Market by Type
  • 3.3.1: Overhead Phototherapy Units: Trends and Forecast (2019 to 2031)
  • 3.3.2: Portable Phototherapy Units: Trends and Forecast (2019 to 2031)
  • 3.3.3: Others: Trends and Forecast (2019 to 2031)
• 3.4: Global Newborn Jaundice Treatment Market by Application
  • 3.4.1: Hospital: Trends and Forecast (2019 to 2031)
  • 3.4.2: Household: Trends and Forecast (2019 to 2031)
  • 3.4.3: Others: Trends and Forecast (2019 to 2031)

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Newborn Jaundice Treatment Market by Region
• 4.2: North American Newborn Jaundice Treatment Market
  • 4.2.1: North American Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.2.2: North American Market by Application: Hospital, Household, and Others
  • 4.2.3: The United States Newborn Jaundice Treatment Market
  • 4.2.4: Mexican Newborn Jaundice Treatment Market
  • 4.2.5: Canadian Newborn Jaundice Treatment Market
• 4.3: European Newborn Jaundice Treatment Market
  • 4.3.1: European Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.3.2: European Market by Application: Hospital, Household, and Others
  • 4.3.3: German Newborn Jaundice Treatment Market
  • 4.3.4: French Newborn Jaundice Treatment Market
  • 4.3.5: Spanish Newborn Jaundice Treatment Market
  • 4.3.6: Italian Newborn Jaundice Treatment Market
  • 4.3.7: The United Kingdom Newborn Jaundice Treatment Market
• 4.4: APAC Newborn Jaundice Treatment Market
  • 4.4.1: APAC Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.4.2: APAC Market by Application: Hospital, Household, and Others
  • 4.4.3: Japanese Newborn Jaundice Treatment Market
  • 4.4.4: Indian Newborn Jaundice Treatment Market
  • 4.4.5: Chinese Newborn Jaundice Treatment Market
  • 4.4.6: South Korean Newborn Jaundice Treatment Market
  • 4.4.7: Indonesian Newborn Jaundice Treatment Market
• 4.5: ROW Newborn Jaundice Treatment Market
  • 4.5.1: ROW Market by Type: Overhead Phototherapy Units, Portable Phototherapy Units, and Others
  • 4.5.2: ROW Market by Application: Hospital, Household, and Others
  • 4.5.3: Middle Eastern Newborn Jaundice Treatment Market
  • 4.5.4: South American Newborn Jaundice Treatment Market
  • 4.5.5: African Newborn Jaundice Treatment Market

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Type
  • 6.1.2: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Application
  • 6.1.3: Growth Opportunities for the Global Newborn Jaundice Treatment Market by Region
• 6.2: Emerging Trends in the Global Newborn Jaundice Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Newborn Jaundice Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Newborn Jaundice Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: GE Healthcare
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.2: Drager
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.3: Bilimetrix
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.4: Philips
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.5: Atom Medical
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.6: Nice Neotech
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.7: MTTS
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.8: Natus Medical
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.9: Delta
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 7.10: Micro Lab
  • Company Overview
  • Newborn Jaundice Treatment Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing